Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company is expected to experience high growth in its overseas formulation business, with innovative drugs in development showing potential for international markets [5][7] - The revenue forecast for 2024 is projected at 1.407 billion RMB, representing a year-on-year growth of 11.75%, with a significant increase in net profit expected in subsequent years [7][8] Financial Performance Summary - **Revenue Forecasts**: - 2023: 1.259 billion RMB - 2024: 1.407 billion RMB (11.75% YoY growth) - 2025E: 1.684 billion RMB (19.68% YoY growth) - 2026E: 2.071 billion RMB (22.98% YoY growth) - 2027E: 2.650 billion RMB (27.96% YoY growth) [6][8] - **Net Profit Forecasts**: - 2023: -190 million RMB - 2024: 31 million RMB - 2025E: 95 million RMB - 2026E: 193 million RMB - 2027E: 330 million RMB [6][8] - **Earnings Per Share (EPS)**: - 2023: -0.95 RMB - 2024: 0.16 RMB - 2025E: 0.48 RMB - 2026E: 0.97 RMB - 2027E: 1.65 RMB [6][8] - **Return on Equity (ROE)**: - 2023: -11.70% - 2024: 1.93% - 2025E: 5.51% - 2026E: 10.05% - 2027E: 14.63% [6][8] Business Growth Drivers - The overseas sales revenue is expected to reach 224 million RMB in 2024, marking a year-on-year increase of approximately 61.96% [7] - The company has made significant progress in registering new products in international markets, including the approval of albumin paclitaxel in the EU [7] - The innovative drug pipeline includes several candidates at various stages of development, indicating potential for future revenue growth [7]

丁一 SAC：S1350524040003 dingyi@huayuanstock.com 证券研究报告 商贸零售 行业点评报告 hyzqdatemark 2025 年 04 月 22 日 证券分析师 周宸宇 zhouchenyu@huayuanstock.com 王悦 wangyue03@huayuanstock.com 板块表现： 2025 年 3 月社零数据点评 投资评级： 看好（维持） ——3 月社零整体同增 5.9%，家具、家电等品类增速较快 投资要点： 分品类看： 请务必仔细阅读正文之后的评级说明和重要声明 3月中国社零增速整体回暖。3月社会消费品零售总额为40940亿元，同比增长5.9%， 除汽车外社会消费品零售总额为 36610 亿元，同比增长 6.0%。分区域来看，3 月城 镇/乡村消费品零售总额分别实现 35595/5345 亿元，分别同比+6.0%/+5.3%。 联系人 按消费类型看，商品增速快于餐饮。3 月限额以上单位消费品零售额为 17239 亿元， 同比增长 8.5%。分类型来看，3 月限额以上商品零售/餐饮收入总额分别为 15899/1340 亿 元 ， 同 比 +8.6%/+6 ...

Investment Rating - The report assigns an "Accumulate" rating for the company, indicating a positive outlook for its future performance [6][10]. Core Views - The company is recognized as a leading player in high-performance composite materials in the aviation sector, benefiting from the synergy between military and civilian markets, which is expected to accelerate its performance release [6][10]. - The company has shown steady growth in operating performance, with significant improvements in financial metrics over the past four years [8][32]. - The demand for high-end carbon fiber composites is anticipated to rise rapidly, driven by military aircraft, civil aviation, aerospace engines, and low-altitude economy sectors [9][56]. Summary by Sections 1. Company Overview - The company is a subsidiary of AVIC and is the only entity in China specializing in the research and engineering of composite materials for aviation, holding a strong competitive position in the industry [7][19]. - The company has a clear business structure with five subsidiaries focusing on different aspects of aviation new materials and advanced manufacturing technology [24][25]. 2. Financial Performance - From 2020 to 2024, the company's revenue and net profit have shown a compound annual growth rate (CAGR) of 14.88% and 27.89%, respectively [8][32]. - In 2024, the company achieved a revenue of 5.072 billion yuan, a year-on-year increase of 6.12%, and a net profit of 1.153 billion yuan, up 11.73% year-on-year [8][32]. 3. Market Demand - The application of composite materials in military aircraft enhances performance by reducing weight and improving stealth capabilities, with the J-20 fighter jet using 27% composite materials [9][56]. - In the civil aviation sector, the C919 aircraft has a composite material application ratio of approximately 12%, with expectations for increased domestic production and demand [9][18]. 4. Profit Forecast and Valuation - The company is projected to achieve net profits of 1.371 billion yuan, 1.606 billion yuan, and 1.837 billion yuan for the years 2025 to 2027, with corresponding growth rates of 18.93%, 17.18%, and 14.35% [12][29]. - The current price-to-earnings (P/E) ratios for 2025, 2026, and 2027 are estimated at 23.71, 20.23, and 17.69, respectively, indicating a favorable valuation compared to peers [12][29].

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [5] Core Views - The company, Xian Tongli, along with its Singapore subsidiary, is expanding globally with a nearly doubled R&D investment to enhance new product technology innovation [5] - In 2024, the company achieved a revenue of 6.145 billion yuan (up 4.85% year-on-year) and a net profit attributable to shareholders of 793 million yuan (up 29.03% year-on-year) [6] - The company is focusing on three main business segments: wide-body dump trucks, parts sales, and maintenance services, all of which showed stable growth in 2024 [6] - The domestic market is recovering, and the overseas market presents significant opportunities, particularly in open-pit coal mining [6] - The company is increasing its R&D expenses by 89% year-on-year, focusing on large-scale, intelligent, and new energy strategies [6] Financial Summary - The company forecasts revenues of 6.507 billion yuan in 2025, with a year-on-year growth rate of 5.90% [8] - The net profit attributable to shareholders is expected to be 803 million yuan in 2025, reflecting a growth rate of 1.28% [8] - The earnings per share (EPS) is projected to be 1.76 yuan in 2025, with a price-to-earnings (P/E) ratio of 12.31 [9] - The company anticipates a steady increase in net profit to 1.007 billion yuan by 2027, with an EPS of 2.20 yuan [9]

证券研究报告 电子 行业定期报告 高端国产化浪潮起，消费电子性价比凸显 投资评级： 看好（维持） ——电子行业周报（20250414-20250420） 投资要点： hyzqdatemark 2025 年 04 月 21 日 证券分析师 葛星甫 SAC：S1350524120001 gexingfu@huayuanstock.com 板块表现： 风险提示：周期复苏不及预期风险、海外宏观环境持续震荡风险、AI 产品落地不及 请务必仔细阅读正文之后的评级说明和重要声明 联系人 本周电子板块行情回顾：参考中证行业指数，本周电子指数下跌 1.02%，其中消费 电子指数下跌 1.23%，半导体指数下跌 0.63%，中美关税冲突引发市场对于电子行 业景气度的担忧。我们认为从行业周期角度来看，当前产业链行业库存正常化进程 正在稳定推进，下游逐步改善，因此周期节奏有望稳健向上；同时中美关税冲突或 将再次引发产业链核心环节的国产化浪潮，重视波动中存在的投资机会。 景气度如何：参考全球半导体芯片销售额同比增速，经历了 2021 年下半年至 2023 年上半年产业链长达两年的去库存之后，于 2023 年下半年随着库存的出清及需求的 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [6] Core Views - The report indicates that goodwill impairment will impact the annual performance, but the medium to long-term growth potential remains intact [6] - The company reported a revenue of 2.354 billion yuan in 2024, a year-on-year decrease of 7.34%, and a net profit attributable to shareholders of 181 million yuan, down 40.84% year-on-year [8] - The report highlights that the military explosives business has optimized capacity, but revenue has declined due to lower average prices and reduced blasting volume [8] Financial Performance Summary - Revenue Forecast: - 2023: 2,541 million yuan - 2024: 2,354 million yuan - 2025E: 2,695 million yuan - 2026E: 3,272 million yuan - 2027E: 3,793 million yuan - Year-on-Year Growth Rates: - 2023: 18.05% - 2024: -7.34% - 2025E: 14.45% - 2026E: 21.44% - 2027E: 15.91% [7] - Net Profit Forecast: - 2023: 306 million yuan - 2024: 181 million yuan - 2025E: 311 million yuan - 2026E: 441 million yuan - 2027E: 572 million yuan - Year-on-Year Growth Rates: - 2023: 112.65% - 2024: -40.84% - 2025E: 72.00% - 2026E: 41.75% - 2027E: 29.90% [7] Market Performance - The report notes that the military explosives integrated business generated 1.646 billion yuan in revenue, a decrease of 5.70% year-on-year, with various segments experiencing declines in revenue [8] - The average price of products such as packaged explosives and electronic detonators decreased by 3.98% and 2.47% respectively [8] - The military new materials business saw a revenue increase of 55.21%, with specific segments like tantalum-niobium oxides growing by 53.32% [8] Profitability Metrics - The integrated military explosives gross margin was 40.24%, an increase of 4.41 percentage points year-on-year [8] - The report indicates that the company expects to complete the production line for energetic materials by the end of September 2025 [8] Valuation Metrics - The report provides a price-to-earnings (P/E) ratio forecast for 2025-2027 as follows: - 2025: 26 - 2026: 18 - 2027: 14 [9]

Investment Rating - The investment rating for the pharmaceutical industry is "Positive" (maintained) [4] Core Viewpoints - The report emphasizes the upcoming launch of S086, a hypertension treatment, which is expected to have significant market potential. The company Sinopharm is highlighted as a key recommendation [3][8] - The report suggests that the pharmaceutical sector is poised for growth due to several factors, including innovation, international expansion, and an aging population. It also notes that the industry has completed a transition from old to new growth drivers [20][39] Summary by Sections 1. S086 - S086, developed by Sinopharm, is the second ARNI drug to enter clinical trials globally, with a significant market potential due to the high prevalence of hypertension in China [12][13] - The drug has shown superior efficacy in clinical trials, particularly in managing nighttime blood pressure and reducing uric acid levels, which positions it favorably against competitors like Novartis' Entresto [12][13] 2. Industry Perspective - The pharmaceutical index has shown a decline of 0.36% from April 14 to April 18, with a year-to-date decline of 1.45%. The report notes that the sector is experiencing a mixed performance with both rising and falling stocks [20][25] - The report identifies key investment themes: innovation, international expansion, and the impact of an aging population on healthcare demand [20][39] 3. Investment Recommendations - The report recommends focusing on innovative pharmaceutical companies and medical devices, particularly those with strong international growth potential and those benefiting from domestic policy support [39][41] - Specific companies highlighted for investment include Sinopharm, Hengrui Medicine, and Kelun Pharmaceutical, among others [39][42]

Investment Rating - The investment rating for the shipping and shipbuilding industry is "Positive" (maintained) [4] Core Insights - The report highlights that global shipping decarbonization plans are being established, which will benefit shipbuilding through economic measures [3] - The International Maritime Organization (IMO) has set various targets and regulatory measures to gradually promote shipping decarbonization, with emission reduction goals based on 2008 levels [6][7] - The report indicates that traditional heavy fuel oil (HFO) and liquefied natural gas (LNG) may not meet the IMO's mid-term decarbonization requirements by 2035 [10] - Ships using HFO may incur compliance costs of approximately $100 per ton between 2028 and 2030, while LNG-fueled ships may be exempt from such costs [10] - The analysis suggests that using fuels with lower greenhouse gas (GHG) content is more effective in reducing potential compliance costs than improving ship efficiency [14] - The IMO's zero-carbon fund has high reward requirements, and only bio-LNG, blue/green methanol, and green ammonia may meet these standards [16] - The report notes that over 80% of the global fleet's capacity currently relies on traditional heavy fuel oil [16] - For ships built before 2015, the inability to retrofit for green fuels will significantly reduce their future economic viability [19] - The report estimates that approximately 60% of existing capacity (ships built before 2015) will need to be replaced with new ships using green fuels by 2030 [20] - As the Carbon Intensity Indicator (CII) requirements increase, the proportion of the global fleet rated D-E may further rise [24]

Investment Rating - The investment rating for the company is "Buy" (maintained) with a current dividend yield of 5% [5] Core Views - The company's performance is being impacted by power restrictions, leading to a decline in profits. The main reasons for the profit decline are reduced wind power profits and lower returns from solar projects despite an increase in installed capacity [7] - The company is expected to focus on high-quality growth rather than blind capital expenditure, leveraging its advantages from being part of the China General Nuclear Power Group [7] - The introduction of a new pricing mechanism for electricity is anticipated to stabilize revenue expectations and promote healthier industry development [7] Financial Summary - The company reported a revenue of 19.51 billion USD in 2024, a decrease of 11% year-on-year, with a net profit of 2.48 billion USD, down 7.3% year-on-year [7] - Revenue projections for the upcoming years are as follows: - 2025E: 14,267 million RMB - 2026E: 14,470 million RMB - 2027E: 14,731 million RMB - Net profit projections are: - 2025E: 1,852 million RMB - 2026E: 1,958 million RMB - 2027E: 2,090 million RMB [6][8] - The company’s price-to-earnings (P/E) ratios for the next three years are projected to be 4.8, 4.5, and 4.3 respectively [7]

Report Overview - Report Title: Short - end Spreads Compressed, Long - end Spreads Widened — Credit Analysis Weekly (2025/4/14 - 2025/4/18) - Report Date: April 20, 2025 - Industry Investment Rating: Not provided in the report Core Views - The 10 - year Treasury yield at 1.65% prices in about a 30BP interest rate cut expectation, and the 10Y Treasury yield may return above 1.7% this year [2] - The credit spreads of various industries fluctuated this week. For urban investment bonds, the 3 - 5Y spreads are inverted with long - end spreads, and it is recommended that institutions with stable liability ends select high - quality urban investment entities in developed regions. For industrial bonds, short - end spreads compressed slightly, and long - end spreads widened slightly, and it is recommended to focus on high - rating short - duration industrial bonds. For bank capital bonds, short - end spreads compressed to varying degrees, and long - end spreads widened slightly, and it is recommended to focus on the catch - up opportunities of secondary capital bonds at the convex points of the term structure [2][44] Summary by Directory 1. This Week's Market Overview (4/14 - 4/18) 1.1 Primary Market - Credit bond issuance, repayment, and net financing: The net financing of credit bonds (excluding asset - backed securities) was 17.96 billion yuan, a decrease of 4.34 billion yuan from last week. The total issuance was 45 billion yuan, an increase of 2.42 billion yuan, and the total repayment was 27.04 billion yuan, an increase of 6.76 billion yuan. The net financing of asset - backed securities was 2.35 billion yuan, a decrease of 2.08 billion yuan [6] - By product type: The net financing of urban investment bonds was 6.28 billion yuan, a decrease of 0.26 billion yuan; that of industrial bonds was 12.78 billion yuan, an increase of 3.97 billion yuan; and that of financial bonds was - 1.1 billion yuan, a decrease of 8.04 billion yuan [6] - Issuance and repayment numbers: Urban investment bond issuance increased by 53 and repayment by 21; industrial bond issuance increased by 102 and repayment by 63; financial bond issuance decreased by 14 and repayment increased by 9 [7] - Issuance costs: Except for the issuance rates of AAA urban investment bonds and financial bonds rising, the issuance rates of other rated credit bonds decreased to varying degrees. For urban investment bonds, AA and AA + rates decreased by 15BP and 2BP respectively; for industrial bonds, AA, AA +, and AAA rates decreased by 15BP, 18BP, and 2BP respectively; AAA urban investment and financial bond rates increased by 1BP and 15BP respectively. For asset - backed securities, AAsf - rated ABS rate increased by 550BP, AA + sf - rated ABS rate decreased by 92BP, AAAsf - rated ABS rate decreased by 9BP, and AA + and AAA - rated ABN costs decreased [15][16] 1.2 Secondary Market - Trading volume: The trading volume of credit bonds (excluding asset - backed securities) decreased by 2.24 billion yuan from last week. Urban investment bond volume increased by 5.65 billion yuan, industrial bond volume increased by 4.3 billion yuan, financial bond volume decreased by 12.2 billion yuan, and asset - backed securities volume increased by 0.9 billion yuan [18] - Turnover rate: The turnover rate of credit bonds fluctuated. Urban investment bond turnover rate was 1.69%, a decrease of 0.36pct; industrial bond turnover rate was 2.14%, an increase of 0.24pct; financial bond turnover rate was 2.71%, a decrease of 0.89pct; asset - backed securities turnover rate was 0.7%, an increase of 0.28pct [18] - Yields: Except for the yields of credit bonds below 1Y decreasing slightly, the yields of credit bonds of other terms and ratings decreased by 0 - 7BP. By variety, taking AA + - rated 5Y bonds as an example, the yields of different varieties fluctuated [22][23] - Credit spreads: The credit spreads of various industries fluctuated slightly. AA - rated pharmaceutical and biological credit bonds narrowed by 10BP; among AA + - rated bonds, the spreads of electronics, chemical, and machinery industries narrowed by 6BP, 5BP, and 5BP respectively, while that of the computer industry widened by 5BP; among AAA - rated bonds, the spread of the electrical equipment industry narrowed by 9BP, and that of the leisure service industry widened by 6BP [25] 2. Urban Investment Bonds - By term: Short - end spreads compressed slightly, and long - end spreads widened slightly. The 0.5 - 1Y spread was 44BP, a compression of 1BP; the 1 - 3Y spread was 51BP, a compression of less than 1BP; the 3 - 5Y spread was 75BP, a compression of 3BP; the 5 - 10Y spread was 66BP, a widening of 3BP; the spread over 10Y was 47BP, a widening of less than 1BP [29] - By region: The credit spreads of urban investment bonds in various regions generally narrowed, with some regions rising slightly. Tianjin, Shanxi, and Gansu's AA - rated spreads compressed by 5BP or more, and the spreads of other regions fluctuated by less than 5BP [31] 3. Industrial Bonds - Credit spreads: Short - end spreads compressed slightly, and long - end spreads widened slightly. After the adjustment of long - end spreads, the convex point of the term spread of AAA - rated industrial bonds has been smoothed out. It is recommended to focus on high - rating short - duration industrial bonds for coupon income and increase positions on dips [33] 4. Bank Capital Bonds - Credit spreads: Short - end spreads compressed to varying degrees, and long - end spreads widened slightly. For secondary capital bonds, the spreads of AAA - 3Y, AA + 1Y and 3Y, and AA 1Y narrowed by 5BP or more, and the spreads of AAA -, AA +, and AA 10Y widened by 2 - 3BP. For bank perpetual bonds, the spreads of AAA -, AA +, and AA 1Y narrowed by 5BP. It is recommended to focus on the catch - up opportunities of secondary capital bonds at the convex points of the term structure [37] 5. This Week's Bond Market Sentiment - Negative sentiment: The implied ratings of "24 Anyang Iron and Steel MTN001 (Sustainable - linked)", "24 Anyang Iron and Steel MTN002 (Science and Technology Innovation Note)", "25 Anyang Iron and Steel PPN001 (Science and Technology Innovation Note)", and "25 Anyang Iron and Steel PPN002B (Science and Technology Innovation Note)" issued by Anyang Iron and Steel Group Co., Ltd. were downgraded [2] 6. Investment Recommendations - Urban investment bonds: Institutions with stable liability ends can select high - quality urban investment entities in developed regions to lock in coupon income and moderately sink to capture arbitrage opportunities at the convex points of the term structure [2][44] - Industrial bonds: Focus on high - rating short - duration industrial bonds for coupon income and increase positions on dips [2][44] - Bank capital bonds: Focus on the catch - up opportunities of secondary capital bonds at the convex points of the term structure [2][44]